• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Delaware Enhanced Global Div and Inc

Delaware Enhanced Global Div and Inc

  1. All
  2. 3rd Party
  1. Adaptive Biotechnologies and Collaborators to Present Data Demonstrating High-Throughput Sequencing for Minimal Residual Disease (MRD) is More Sensitive Than Flow Cytometry and Can Be Used as a ...

    Adaptive Biotechnologies and Collaborators to Present Data Demonstrating High-Throughput Sequencing for Minimal Residual Disease (MRD) is More Sensitive Than Flow Cytometry and Can Be Used as a Determinant of Early Response to Therapy

  2. Pooled Data from Meta-Analysis Suggest Significant Overall Survival Benefit of Investigational REVLIMID® Maintenance Following Autologous Stem Cell Transplant in Multiple Myeloma

    Pooled Data from Meta-Analysis Suggest Significant Overall Survival Benefit of Investigational REVLIMID® Maintenance Following Autologous Stem Cell Transplant in Multiple Myeloma

  3. UPDATE: Stress in corporate credit markets improves, but not for a good reason

    UPDATE: Stress in corporate credit markets improves, but not for a good reason

  4. UPDATE: Stress in corporate credit markets improves, but not for a good reason

    UPDATE: Stress in corporate credit markets improves, but not for a good reason

  5. 6 Must-Knows About Strategic Beta Funds

    What they are, where they came from, where they're going--and how to evaluate them. 

  6. Nearing the End of a Decent Year in CEFs

    Falling oil prices buffet some CEFs, but many have turned out strong returns so far this year.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.